Arvind Limited (BOM:500101)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	82,384	82,525	70,679	22,319	30,098	17,011
Market Cap Growth	-4.53%	16.76%	216.68%	-25.85%	76.93%	232.86%
Enterprise Value	98,292	98,056	85,823	41,270	50,406	39,426
Last Close Price	314.50	311.73	263.84	80.00	108.26	61.58
PE Ratio	22.43	23.35	21.00	5.52	12.64	-
Forward PE	18.54	17.10	15.44	5.89	8.46	11.18
PS Ratio	0.97	0.99	0.91	0.27	0.38	0.34
PB Ratio	2.13	2.13	1.95	0.66	1.00	0.62
P/TBV Ratio	2.19	2.19	2.01	0.67	1.03	0.64
P/FCF Ratio	-	36.23	16.89	4.83	7.36	2.58
P/OCF Ratio	-	10.82	10.15	3.35	5.06	2.19
PEG Ratio	0.61	4.67	4.67	4.67	4.67	4.67
EV/Sales Ratio	1.16	1.18	1.11	0.49	0.63	0.78
EV/EBITDA Ratio	10.97	11.68	10.36	5.06	6.07	8.75
EV/EBIT Ratio	15.28	15.88	14.45	7.33	8.74	20.07
EV/FCF Ratio	-	43.05	20.51	8.94	12.33	5.97
Debt / Equity Ratio	0.40	0.40	0.40	0.45	0.62	0.77
Debt / EBITDA Ratio	1.74	1.79	1.70	1.86	2.25	4.41
Debt / FCF Ratio	-	6.86	3.46	3.29	4.56	3.22
Asset Turnover	-	1.09	1.09	1.15	1.11	0.73
Inventory Turnover	-	2.04	2.17	2.44	2.64	2.16
Quick Ratio	-	0.36	0.38	0.38	0.37	0.49
Current Ratio	-	1.08	1.12	1.10	1.11	1.12
Return on Equity (ROE)	-	9.81%	10.04%	13.00%	9.28%	-0.99%
Return on Assets (ROA)	-	5.03%	5.24%	4.82%	5.00%	1.77%
Return on Capital (ROIC)	7.67%	7.35%	7.43%	7.19%	7.38%	2.38%
Return on Capital Employed (ROCE)	-	13.50%	14.30%	13.80%	14.20%	4.80%
Earnings Yield	4.46%	4.28%	4.76%	18.13%	7.91%	-0.97%
FCF Yield	-	2.76%	5.92%	20.69%	13.58%	38.82%
Dividend Yield	1.19%	1.20%	1.42%	4.69%	-	-
Payout Ratio	-	36.77%	45.82%	-	-	-
Buyback Yield / Dilution	-0.03%	-0.07%	-0.33%	-0.05%	-1.04%	0.27%
Total Shareholder Return	1.17%	1.13%	1.09%	4.63%	-1.04%	0.27%

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.